A combination of sacubitril and valsartan (ARB) used for heart failure.
Sacubitrilat blocks the activity of enzyme neprilysin responsible for the degradation of blood pressure-lowering peptides that work mainly by reducing blood volume, relaxing blood vessels, decreasing sodium and fluid in the body.
Sacubitrilat blocks the activity of enzyme neprilysin responsible for the degradation of blood pressure-lowering peptides that work mainly by reducing blood volume, relaxing blood vessels, decreasing sodium and fluid in the body.
